464 related articles for article (PubMed ID: 29096683)
1. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
[TBL] [Abstract][Full Text] [Related]
2. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
Chen J; Zhao X; Ye Y; Wang Y; Tian J
Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
[TBL] [Abstract][Full Text] [Related]
4. Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα.
Wang Y; Xie W; Hou M; Tian J; Zhang X; Ren Q; Huang Y; Chen J
Aging (Albany NY); 2021 Mar; 13(8):11026-11042. PubMed ID: 33647882
[TBL] [Abstract][Full Text] [Related]
5. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
6. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1.
Li Y; Miao H; Wei W; Tian J; Chen J
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):225-236. PubMed ID: 36647722
[TBL] [Abstract][Full Text] [Related]
8. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo.
Wei W; Chen ZJ; Zhang KS; Yang XL; Wu YM; Chen XH; Huang HB; Liu HL; Cai SH; Du J; Wang HS
Cell Death Dis; 2014 Oct; 5(10):e1428. PubMed ID: 25275589
[TBL] [Abstract][Full Text] [Related]
9. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7.
Tian J; Duan YX; Bei CY; Chen J
Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007
[TBL] [Abstract][Full Text] [Related]
10. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
Chen J; Lin C; Yong W; Ye Y; Huang Z
Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518
[TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S
J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
Wu G; Niu M; Qin J; Wang Y; Tian J
Gene; 2019 Aug; 709():48-55. PubMed ID: 31002890
[TBL] [Abstract][Full Text] [Related]
13. Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα.
Chen J; Zhang X; Wang Y; Ye Y; Huang Z
Mol Carcinog; 2018 Jul; 57(7):817-830. PubMed ID: 29722068
[TBL] [Abstract][Full Text] [Related]
14. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
15. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
16. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
18. Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways.
Kong L; Li X; Wang H; He G; Tang A
Biomed Pharmacother; 2018 Oct; 106():342-348. PubMed ID: 29966979
[TBL] [Abstract][Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
20. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
Zhao X; Li X; Ren Q; Tian J; Chen J
Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
